Ask Your Doctor About

Summary of Ask Your Doctor About

by Roman Mars

32mMay 12, 2026

Overview of Ask Your Doctor About

This episode of 99% Invisible explores the strange, highly regulated, and surprisingly creative world of pharmaceutical brand naming. Roman Mars and Sean Cole dig into why prescription drugs often sound futuristic, awkward, or oddly poetic—and reveal that those names are not random at all. Behind them is a mix of marketing strategy, FDA rules, trademark constraints, and, in some cases, genuine linguistic artistry.

Why Drug Names Sound So Weird

Sean’s original question is simple: why do so many drug names sound like sci-fi villains or scrambled syllables? The episode explains that the weirdness is largely driven by the need to:

  • Create a name that is distinctive and trademarkable
  • Avoid promising too much in the name itself
  • Prevent confusion with existing drugs, since lookalike/soundalike names can cause deadly medication errors
  • Work across global regulatory systems, where the same name needs approval in many countries

The result is a naming process that often forces brands away from ordinary words and toward invented, highly differentiated forms.

How Pharmaceutical Names Are Created

The episode interviews naming experts, especially people from the Brand Institute, which helps name a large share of new drugs. The process is much more methodical than a quick brainstorming session:

The naming workflow

  • Meet with the client company to understand the product and its goals
  • Generate hundreds of possible names
  • Narrow them down based on:
    • pronunciation
    • legal availability
    • regulatory approval
    • visual distinctiveness
    • marketability

Sources of name ideas

Names may come from:

  • word fragments
  • foreign language references
  • linguistic patterns like palindromes or anagrams
  • the drug’s mechanism of action
  • the emotional or aspirational outcome the drug is meant to suggest

The episode also notes that the company now uses an AI tool called Brandy to help with early-stage ideation, though humans still do most of the creative work.

The FDA’s Role in Drug Naming

A major force shaping drug names is the FDA, which discourages names that are misleading or too similar to existing medications.

Two big FDA concerns

  1. No exaggerated claims

    • A name can’t sound like a miracle cure.
    • This is why many names hint at an effect without explicitly stating one.
  2. Avoid confusion with other drugs

    • The episode gives the example of LASIX and LOSEC, whose similarity contributed to a fatal hospital mix-up.
    • To reduce that risk, namers pay attention to the shape of the word on the page.

Visual “silhouette” matters

Drug names are often designed to have a mix of:

  • ascending letters like l, t, h
  • descending letters like p, q, g
  • varied visual structure

This helps make names easier to distinguish in writing, especially in handwritten prescriptions.

Famous Examples and Naming Logic

The episode uses several drugs to show how naming works in practice:

Lunesta

  • Suggested through lunar imagery
  • The “-esta” sound implies rest or sleep, like siesta

Ambien

  • Built around the idea of the morning after and waking up refreshed

Belsomra

  • Combines a sleep-related root with a softer, more elegant sound

Imdelltra

  • A cancer drug name that encodes the product’s mechanism of action
  • Demonstrates how oncology names often prioritize scientific cues because the audience is primarily doctors, not consumers

Toujeo

  • An insulin brand name with a poetic backstory
  • Inspired by the idea of being a “friend for life” and the drug’s longer duration of action
  • Connected etymologically to meanings like “always” or “every day”

Viagra

The most memorable story in the episode is about Viagra:

  • Naming consultant Arlene originally coined it for a different drug
  • She combined ideas of:
    • vigorous
    • Niagara
  • The name was later reused by Pfizer for erectile dysfunction, where it became iconic

The episode emphasizes that this was less a grand branding masterstroke and more a chain of creative associations that happened to land perfectly.

The History of Modern Drug Naming

The episode marks Prozac as a turning point in pharmaceutical branding.

Why Prozac mattered

  • It was one of the first blockbuster drug names that felt short, punchy, and brand-forward
  • It worked as a kind of “blank canvas” name: emotionally suggestive but not overly literal
  • Its success helped set the tone for modern naming conventions

From there, drug names became more carefully engineered and more numerous, especially as the number of approved drugs increased dramatically over time.

Drug Naming as Both Science and Poetry

One of the episode’s main ideas is that drug naming is not just bureaucratic branding—it’s also a form of creative writing.

The poetic side

Arlene, one of the naming experts featured, is also a haiku poet. She says the same thing matters in both disciplines:

  • the sound of the word
  • how it feels in the mouth
  • whether it flows naturally in speech

That’s why a name like Viagra feels easy to say, while something like Imdelltra can feel clunkier.

The hidden narrative in names

The episode argues that many drug names carry an emotional or conceptual story underneath them, even if listeners or patients never consciously notice it. In that sense, the name is meant to evoke a feeling more than spell out a message.

Key Takeaways

  • Drug names are carefully engineered, not randomly invented.
  • The FDA pushes names toward safety, clarity, and non-claiming language.
  • Visual and phonetic distinctiveness are crucial to avoid dangerous mix-ups.
  • Naming is constrained by 26 letters, global regulation, and trademark law, which makes originality increasingly difficult.
  • Despite the constraints, the best names often have a poetic quality—they sound right, feel right, and hint at a story.
  • The episode reframes pharmaceutical naming as a legitimate creative craft, somewhere between branding, linguistics, and poetry.

Notable Insight

A central idea from the episode is that a strong drug name should not just be clever—it should be pronounceable, memorable, safe, and emotionally resonant. In other words, the best names are designed to live comfortably in everyday speech while still standing out in a crowded market.